Topic: Biotech
As half of the world struggles to meet energy needs at a reasonable price and the other half strives to develop cleaner energy solutions, Alexis Belonio does both. In this interview by Stanford Center for Social Innovation correspondent Sheela Sethuraman, we hear from Alexis Belonio, of the Center for Rice and Husk Technology, as he joins the Prize Laureates from the 2010 Tech Museum Awards. He discusses how he is changing the world by providing a clean burning and accessible source of energy for all.
Dr. Moira Gunn talks with the Director of Personalized Medicine for Life Technologies, Linh Hoang, about personalized medicine, and what that means for a breast cancer study with just 14 select women.
Dr. Moira Gunn talks with Dr. Paul Chew, Chief Scientific and Medical Officer for the US division of Sanofi-Aventis, touching on the latest from Diabetes to triple-negative breast cancer. She then talks with Chris Stern, CEO of Oxygen Biotherapeutics about their innovative oxygen carriers.
Dr. Moira Gunn learns about two vaccines: the first intended for prevention and the second, for people already infected with HIV, from Geovax President and CEO, Robert McNally.
Dr.Moira Gunn talks first with Eric Lawson, Director of Regulatory Affairs for Voisin and OJ Bio CEO, Dale Athey about advances in diagnostic testing. She then chances up with Paul Weinberger, Chief Marketing Officer, Lumora about their fast DNA and RNA testing from a small device.
Dr. Moria Gunn looks to the future of computers and biotechnology, with Anaris President and CEO, Joan Lau.
Dr. Moira Gunn talks with Tom Thorton, President & CEO of Kansas Bioscience Authority, where they are working on biodefense in food safety.
Dr, Moira Gunn catches up on the latest advances in antibodies and combating fibrosis disease with the Senior Vice President for BioInvent, Martin Wiles and Chief Business Officer at Amira Pharmaceuticals, Hari Kumar.
Dr. Moira Gunn talks about a new treatment for Glioblastoma with ImmunoCellular CEO, Manish Singh.
Dr. Moira Gunn splits her time this week between Barbara Domayne-Hayman of Stabilitech and Matthew Durdy of Aqix. Stabilitech are working on a technology which eliminates the need to refrigerate vaccines, while Aqix have designed an innovative technology which looks to replace the saline drip.
